Ticker LaunchIPO · ALGS
Aligos Therapeutics, Inc.
Aligos Therapeutics, Inc. (ALGS) priced its initial public offering on Oct 19, 2020 at $15.00 per share, within its $14.00–$16.00 range, raising $150M, and listed on Nasdaq Global Select. At the IPO price its market capitalization was about $553.4M. J.P. Morgan was lead-left underwriter, joined by Jefferies, Piper Sandler and Cantor. Latham & Watkins advised the company and Davis Polk advised the underwriters.
- Status
- IPO
- Ticker
- ALGS
- Exchange
- Nasdaq Global Select
- Priced
- Oct 19, 2020
- IPO price
- $15.00
- Price range
- $14.00–$16.00
- Raised
- $150M
- Market cap at IPO price
- $553.4M
- First filed
- Sep 25, 2020
- Underwriters
- J.P. Morgan, Jefferies, Piper Sandler and Cantor
- Company counsel
- Latham & Watkins
- Underwriters' counsel
- Davis Polk
- Sector
- Biotech & pharma
- Country / state
- CA
Market cap at IPO price = shares outstanding after the offering (all classes, before the over-allotment option) × the IPO price, from the final prospectus.
More on this listing for subscribers
- Lock-up period and expiry date
- Analyst notes on the filing
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- Registration statement (S-1) first filed Sep 25, 2020
- Latest amendment Oct 9, 2020
- Final prospectus (424B4) Oct 19, 2020
- All filings on EDGAR CIK 1799448
Other Biotech & pharma IPOs in 2020
- Foghorn Therapeutics Inc.FHTX · Oct 23, 2020 · $120M
- Abcam plcABCM · Oct 22, 2020 · $156.5M
- Opthea LtdOPT · Oct 19, 2020
- Kiromic Biopharma, Inc.KRBP · Oct 16, 2020 · $15M
- Praxis Precision Medicines, Inc.PRAX · Oct 16, 2020 · $190M
- Tarsus Pharmaceuticals, Inc.TARS · Oct 16, 2020 · $88M